Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 2011

View Archived Issues

PSMA-ADC appears safe in first-in-human study in taxane-refractory metastatic CRPC

Interim phase I data support safety of tremelimumab plus bicalutamide in recurrent prostate cancer

Intraprostatic administration of PROSTVAC VF cancer vaccine is feasible and safe

Zymes receives Michael J. Fox Foundation grant to assess WS-CoQ10 for Parkinson's disease

Tariquidar is safe in combination with docetaxel in patients with cancer

Shire reviews progress of fourth quarter 2010

Multistage tuberculosis vaccine H-56 combats late-stage infection in vivo

Vical and U.S. government extend collaboration to develop vaccines against emerging diseases

Eisai's warfarin potassium tablets approved in Japan for pediatric use

Novel tyrosine-protein kinase SYK inhibitors described by IRM

Laboratorios Salvat presents novel APAF-1 inhibitors

Dainippon Sumitomo Pharma reports on third quarter fiscal 2010

Roche presents novel P2X7 receptor modulators

Sun Pharma and Caraco enter merger agreement

Proacta and Yakult Honsha enter PR-509 development agreement

Nesina approved in Japan for additional indications in type 2 diabetes

New HSL inhibitors claimed

Stamford Hospital participates in FDA's Expanded Access program for Generex Oral-lyn

Elan and PPD form global drug development collaboration

Phase III Heplisav trials cleared by safety monitoring board to continue

Argon Pharma discovers new prostaglandin G/H synthase 2 inhibitors

Delcath Systems receives FDA refusal to file letter for chemosaturation system

Tranzyme Pharma and Norgine start phase III trial of ulimorelin for postoperative ileus

Japanese approval granted for Sosei's NorLevo emergency contraceptive pill

FDA grants fast track status to Sunesis' Vosaroxin in AML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...